1
|
Bakhrushina EO, Sakharova PS, Konogorova PD, Pyzhov VS, Kosenkova SI, Bardakov AI, Zubareva IM, Krasnyuk II, Krasnyuk II. Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction. Pharmaceutics 2024; 16:115. [PMID: 38258125 PMCID: PMC10819773 DOI: 10.3390/pharmaceutics16010115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 01/04/2024] [Accepted: 01/12/2024] [Indexed: 01/24/2024] Open
Abstract
In modern pharmaceutical technology, modified-release dosage forms, such as in situ formed implants, are gaining rapidly in popularity. These dosage forms are created based on a configurable matrix consisting of phase-sensitive polymers capable of biodegradation, a hydrophilic solvent, and the active substance suspended or dissolved in it. The most used phase-sensitive implants are based on a biocompatible and biodegradable polymer, poly(DL-lactide-co-glycolide) (PLGA). OBJECTIVE This systematic review examines the reasons for the phenomenon of active ingredient "burst" release, which is a major drawback of PLGA-based in situ formed implants, and the likely ways to correct this phenomenon to improve the quality of in situ formed implants with a poly(DL-lactide-co-glycolide) matrix. DATA SOURCES Actual and relevant publications in PubMed and Google Scholar databases were studied. STUDY SELECTION The concept of the review was based on the theory developed during literature analysis of 12 effectors on burst release from in situ forming implants based on PLGA. Only those studies that sufficiently fully disclosed one or another component of the theory were included. RESULTS The analysis resulted in development of a systematic approach called the "12 Factor System", which considers various constant and variable, endogenous and exogenous factors that can influence the nature of 'burst release' of active ingredients from PLGA polymer-based in situ formed implants. These factors include matrix porosity, polymer swelling, LA:GA ratio, PLGA end groups, polymer molecular weight, active ingredient structure, polymer concentration, polymer loading with active ingredients, polymer combination, use of co-solvents, addition of excipients, and change of dissolution conditions. This review also considered different types of kinetics of active ingredient release from in situ formed implants and the possibility of using the "burst release" phenomenon to modify the active ingredient release profile at the site of application of this dosage form.
Collapse
Affiliation(s)
| | | | | | - Victor S. Pyzhov
- Department of Pharmaceutical Technology, A.P. Nelyubin Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia; (E.O.B.); (P.S.S.); (P.D.K.); (S.I.K.); (A.I.B.); (I.M.Z.); (I.I.K.); (I.I.K.J.)
| | | | | | | | | | | |
Collapse
|
2
|
Senarat S, Pornsawad P, Lertsuphotvanit N, Østergaard J, Phaechamud T. Numerical Mechanistic Modelling of Drug Release from Solvent-Removal Zein-Based In Situ Gel. Pharmaceutics 2023; 15:2401. [PMID: 37896160 PMCID: PMC10609933 DOI: 10.3390/pharmaceutics15102401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2023] [Revised: 09/21/2023] [Accepted: 09/27/2023] [Indexed: 10/29/2023] Open
Abstract
The development of effective drug delivery systems remains a focus of extensive research to enhance therapeutic outcomes. Among these, in situ forming gels (ISG) have emerged as a promising avenue for controlled drug release. This research focuses on the mathematical modeling of levofloxacin HCl (Lv) release from zein-based ISG using the cup method, aiming to mimic the environment of a periodontal pocket. The drug release behavior of the ISGs was investigated through experimental observations and numerical simulations employing forward and central difference formula. Notably, the experimental data for drug release from the 20% w/w zein-based ISG formulations closely aligned with the simulations obtained from numerical mechanistic modeling. In summary, 20% w/w zein-based ISG formulations demonstrated nearly complete drug release with the maximum drug concentration at the edge of the matrix phase values consistently around 100-105%, while 25% w/w zein-based ISG formulations exhibited somewhat lower drug release extents, with values ranging from 70-90%. Additionally, the rate of drug transport from the polymer matrix to the external phase influenced initial release rates, resulting in a slower release. The utilization of glycerol formal as a solvent extended drug release further than dimethyl sulfoxide, thanks to denser matrices formed by high-loading polymers that acted as robust barriers to solvent removal and drug diffusion. Furthermore, UV-vis imaging was utilized to visualize the matrix formation process and solvent diffusion within the ISGs. The imaging results offered valuable insights into the matrix formation kinetics, controlled drug release mechanisms, and the influence of solvent properties on drug diffusion. The combination of mathematical modeling and experimental visualization provides a comprehensive understanding of drug release from zein-based ISGs and offers a foundation for tailored drug delivery strategies.
Collapse
Affiliation(s)
- Setthapong Senarat
- Programme of Pharmaceutical Engineering, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand;
| | - Pornsarp Pornsawad
- Department of Mathematics, Faculty of Science, Silpakorn University, Nakhon Pathom 73000, Thailand;
| | - Nutdanai Lertsuphotvanit
- Program of Pharmaceutical Technology, Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand;
| | - Jesper Østergaard
- Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark;
| | - Thawatchai Phaechamud
- Programme of Pharmaceutical Engineering, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand;
- Program of Pharmaceutical Technology, Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand;
- Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand
- Natural Bioactive and Material for Health Promotion and Drug Delivery System Group (NBM), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand
| |
Collapse
|
3
|
Yin LN, Zhang YW, Huang WH, Wang SH, Zheng GL. Stereoselectivity evaluation of chiral chitosan microspheres delivery system containing rac-KET in vitro and in vivo. Drug Deliv 2019; 26:63-69. [PMID: 30744429 PMCID: PMC6374939 DOI: 10.1080/10717544.2018.1556360] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
The influence of chiral excipient D-chitosan (CS) on the stereoselective release of racemic ketoprofen (rac-KET) microspheres has been investigated in comparison to those microspheres containing individual enantiomers in vitro and in vivo. Stereoselectivity was observed in vitro release test, with R-KET release slightly higher than that of S-KET, especially in 3% rac-KET loading microspheres. Stereoselectivity is dependent on the content of chiral excipient and pH of release medium. A molecular docking study between CS and KET enantiomers further revealed that S-KET has a stronger interaction with CS compared to R-KET. Moreover, the plasma concentration of KET enantiomers in rats shows substantial differences, as the plasma levels of S-KET were higher than those of R-KET. Plasma levels of enantiomers from the R-KET microspheres had similar stereoselectivity as rac-KET microspheres. The S/R ratio of rac-KET microspheres was significantly lower than that of rac-KET suspension (regular-release formulation) (p<.05), and the differences is 3–5 fold. Besides, rates of R-KET converted to S-KET exhibited differences between rac-KET microspheres and suspension. Similar results were also found between R-KET microspheres and suspension. All investigations suggest that the chitosan interacting preferentially with S-KET to R-KET significantly affect the stereoselective pharmacokinetics of rac-KET from chitosan microspheres in rats.
Collapse
Affiliation(s)
- Li-Na Yin
- a Institute of Materia Medica, Zhejiang Academy of Medical Sciences , Hangzhou , China
| | - Ya-Wen Zhang
- a Institute of Materia Medica, Zhejiang Academy of Medical Sciences , Hangzhou , China
| | - Wen-Hai Huang
- a Institute of Materia Medica, Zhejiang Academy of Medical Sciences , Hangzhou , China
| | - Sheng-Hao Wang
- a Institute of Materia Medica, Zhejiang Academy of Medical Sciences , Hangzhou , China
| | - Gao-Li Zheng
- a Institute of Materia Medica, Zhejiang Academy of Medical Sciences , Hangzhou , China
| |
Collapse
|
4
|
Haley RM, von Recum HA. Localized and targeted delivery of NSAIDs for treatment of inflammation: A review. Exp Biol Med (Maywood) 2019; 244:433-444. [PMID: 29996674 PMCID: PMC6546999 DOI: 10.1177/1535370218787770] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
IMPACT STATEMENT This work provides an overview of research currently being done exploring potential drug delivery device strategies for NSAIDs as an alternative to systemic delivery. Commentary on this field is made in an attempt to aid future experimental design, enabling researchers to determine the drugs and delivery vehicles which are most advantageous for them to pursue, as well as suggestions to standardize the reporting of such future research.
Collapse
Affiliation(s)
- Rebecca M Haley
- Department of Biomedical Engineering,
Case
Western Reserve University, Cleveland,
OH 44106, USA
| | - Horst A von Recum
- Department of Biomedical Engineering,
Case
Western Reserve University, Cleveland,
OH 44106, USA
| |
Collapse
|
5
|
Gadomska-Gajadhur A, Wrzecionek M, Matyszczak G, Piętowski P, Więcław M, Ruśkowski P. Optimization of Poly(glycerol sebacate) Synthesis for Biomedical Purposes with the Design of Experiments. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00306] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Agnieszka Gadomska-Gajadhur
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Michał Wrzecionek
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Grzegorz Matyszczak
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Piotr Piętowski
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Michał Więcław
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Paweł Ruśkowski
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| |
Collapse
|
6
|
Gadomska-Gajadhur A, Synoradzki L, Ruśkowski P. Poly(lactic acid) for Biomedical Application–Synthesis of Biocompatible Mg Catalyst and Optimization of Its Use in Polymerization of Lactide with the Aid of Design of Experiments. Org Process Res Dev 2018. [DOI: 10.1021/acs.oprd.8b00165] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Agnieszka Gadomska-Gajadhur
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Ludwik Synoradzki
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| | - Paweł Ruśkowski
- Laboratory of Technological Process, Faculty of Chemistry, Warsaw University of Technology, ul. Noakowskiego 3, 00-664 Warsaw, Poland
| |
Collapse
|
7
|
Jiang B, Zhou XN, Zhang HB, Tao Y, Huo LL, Liu N. Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control. Infect Dis Poverty 2017; 6:140. [PMID: 28911334 PMCID: PMC5599885 DOI: 10.1186/s40249-017-0357-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Accepted: 08/31/2017] [Indexed: 01/27/2023] Open
Abstract
BACKGROUND Echinococcosis is a serious, zoonotic, parasitic disease with worldwide distribution. According to a epidemiological survey in 2012 in China, there are 20,000 infected patients and more than 50 million people at the risk. As the dog is the main, definitive host, the Government of China encourages monthly praziquantel treatment of every dog. However, this is difficult to achieve in geographically challenging areas, such as the Tibetan plateau, where there are also many dogs without owners. To overcome these problems, we investigated the transmission blocking capacity of a slow-release formulation of praziquantel administered by subcutaneous injection. METHODS The impact of a slow-release preparation of two pharmacokinetically stereoselective praziquantel enantiomers, i.e., R-(-)-praziquantel (R-PZQ) and S-(+)-praziquantel (S-PZQ) absorbed into a biodegradable polymer was studied in beagle dogs (N = 6). The preparation was given by subcutaneous injection using a single dose of 100 mg/kg. Chiral-selective, high-performance liquid chromatography (HPLC) and high-resolution mass spectrometry (HRMS) were applied to measure the praziquantel enantiomers in the plasma of the dogs. The lower limit for estimating plasma concentrations accurately for R-PZQ was 4 ng/ml and for S-PZQ 20 ng/ml. The pharmacokinetic parameters were calculated by a noncompartmental analysis model using Drug Analyze System (DAS) software 2.0. The SPSS 19.0 software was used for statistical analysis, and the statistical comparison between enantiomers was assessed using the two-tailed t-test. RESULTS Two hours after administration, peak concentrations of R-PZQ and S-PZQ: 321 ± 26 and 719 ± 263 ng/ml, respectively, were achieved. After 180 days, the average plasma concentration of R-PZQ in the six dogs had decreased to 13 ng/ml. The average concentration value of S-PZQ was higher than that of R-PZQ in the first 90-day period but fell afterwards and could not be accurately estimated when dropping below 20 ng/ml (the lower methodological limit for this enantiomer). Taking all the dogs into account, the average maximum concentration (Cmax) of S-PZQ in plasma over the first 3 months was higher than that of R-PZQ by 114.0% (P < 0.05), while the average mean retention time (MRT) of R-PZQ in plasma was higher than that of S-PZQ by 96.3% (P < 0.05). CONCLUSIONS Praziquantel given as an in situ slow-release formulation by subcutaneous injection resulted in concentrations of the active principle in beagle dogs, which should be capable of resisting new Echinococcus infections for at least 6 months. The new formulation of praziquantel represents a potential, alternative way of presenting medication against tapeworm infections in dogs.
Collapse
Affiliation(s)
- Bin Jiang
- National institute of parasitic Diseases, Chinese Center for Disease Control and Prevention, 207 Ruijin Er Road, Shanghai, 200025 China
| | - Xiao-Nong Zhou
- National institute of parasitic Diseases, Chinese Center for Disease Control and Prevention, 207 Ruijin Er Road, Shanghai, 200025 China
- Key Laboratory of Parasite and Vector Biology, Ministry of Health, 207 Ruijin Er Road, Shanghai, 200025 China
- National Center for International Research on Tropical Diseases, Ministry of Science and Technology, 207 Ruijin Er Road, Shanghai, 200025 China
- WHO Collaborating Centre for Tropical Diseases, 207 Ruijin Er Road, Shanghai, 200025 China
| | - Hao-Bing Zhang
- National institute of parasitic Diseases, Chinese Center for Disease Control and Prevention, 207 Ruijin Er Road, Shanghai, 200025 China
| | - Yi Tao
- National institute of parasitic Diseases, Chinese Center for Disease Control and Prevention, 207 Ruijin Er Road, Shanghai, 200025 China
| | - Le-Le Huo
- National institute of parasitic Diseases, Chinese Center for Disease Control and Prevention, 207 Ruijin Er Road, Shanghai, 200025 China
| | - Ni Liu
- National institute of parasitic Diseases, Chinese Center for Disease Control and Prevention, 207 Ruijin Er Road, Shanghai, 200025 China
| |
Collapse
|
8
|
|
9
|
Tsutsumi C, Watanabe R, Tokumaru A, Kuwaoka N, Nakayama Y, Shiono T. Effects of supercritical carbon dioxide treatment on the morphology of poly(l-lactide). J Appl Polym Sci 2016. [DOI: 10.1002/app.44006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Chikara Tsutsumi
- Department of Applied Chemistry and Biotechnology; National Institute of Technology, Niihama College; 7-1 Yagumo-cho Niihama, Ehime 792-8580 Japan
| | - Ryouji Watanabe
- Department of Applied Chemistry and Biotechnology; National Institute of Technology, Niihama College; 7-1 Yagumo-cho Niihama, Ehime 792-8580 Japan
| | - Ayaka Tokumaru
- Department of Applied Chemistry and Biotechnology; National Institute of Technology, Niihama College; 7-1 Yagumo-cho Niihama, Ehime 792-8580 Japan
| | - Nao Kuwaoka
- Department of Applied Chemistry and Biotechnology; National Institute of Technology, Niihama College; 7-1 Yagumo-cho Niihama, Ehime 792-8580 Japan
| | - Yuushou Nakayama
- Department of Applied Chemistry; Graduate School of Engineering, Hiroshima University; 1-4-1, Kagamiyama Higashi-Hiroshima, Hiroshima 739-8527 Japan
| | - Takeshi Shiono
- Department of Applied Chemistry; Graduate School of Engineering, Hiroshima University; 1-4-1, Kagamiyama Higashi-Hiroshima, Hiroshima 739-8527 Japan
| |
Collapse
|
10
|
Yu H, Yong X, Liang J, Deng J, Wu Y. Materials Established for Enantioselective Release of Chiral Compounds. Ind Eng Chem Res 2016. [DOI: 10.1021/acs.iecr.6b01031] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Huli Yu
- State
Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, China
- College
of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
| | - Xueyong Yong
- State
Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, China
- College
of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
| | - Junya Liang
- State
Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, China
- College
of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
| | - Jianping Deng
- State
Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, China
- College
of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
| | - Youping Wu
- College
of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
- State
Key Laboratory of Organic−Inorganic Composites, Beijing University of Chemical Technology, Beijing 100029, China
| |
Collapse
|
11
|
Liang J, Deng J. Chiral porous hybrid particles constructed by helical substituted polyacetylene covalently bonded organosilica for enantioselective release. J Mater Chem B 2016; 4:6437-6445. [DOI: 10.1039/c6tb01757f] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
A new type of chiral porous hybrid particle was successfully prepared and applied in enantioselective release.
Collapse
Affiliation(s)
- Junya Liang
- State Key Laboratory of Chemical Resource Engineering and College of Materials Science and Engineering
- Beijing University of Chemical Technology
- Beijing 100029
- China
| | - Jianping Deng
- State Key Laboratory of Chemical Resource Engineering and College of Materials Science and Engineering
- Beijing University of Chemical Technology
- Beijing 100029
- China
| |
Collapse
|
12
|
Zhang X, Zhang C, Zhang W, Meng S, Liu D, Wang P, Guo J, Li J, Guan Y, Yang D. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation. Drug Dev Ind Pharm 2013; 41:342-52. [PMID: 24320881 DOI: 10.3109/03639045.2013.866140] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
The purpose of this study was to evaluate the technical feasibility of poly (ϵ-caprolactone-co-DL-lactide), P (CL/DL-LA), for injectable in situ forming implants (ISFI). The ISFI was prepared by dissolving P (CL/DL-LA) in N-methyl-2-pyrrolidone (NMP), and Testosterone undecanoate (TU) was used as model drug. The effect of various polymer concentrations, molecular weights (Mws) and drug loads on the drug release from the TU-loaded ISFI systems was investigated in vitro. The release of TU-loaded ISFI was also evaluated in rats. In addition, a subcutaneous rabbit model was used to evaluate the degradation and foreign-body reaction of P (CL/DL-LA) ISFI. The use of higher concentration of P (CL/DL-LA) with higher molecule weight and larger CL:DL-LA monomer ratio for the TU-loaded ISFI gave a slower drug release. The ISFI of 80/20 P (CL/DL-LA) (Mw 61 753):NMP 20:80 with 16% TU formulation increased serum testosterone levels in rats over a period of three months. The in vivo degradation and biocompatibility study of ISFI shows that P (CL/DL-LA) degrades by a process of bulk degradation and that the foreign-body reaction of this biomaterial is relatively mild. In summary, our investigations demonstrate that in situ parenteral drug delivery systems can be obtained from P (CL/DL-LA) solutions.
Collapse
Affiliation(s)
- Xiaowei Zhang
- Liaoning Research Institute of Family Planning , Shenyang , People's Republic of China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A. PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release. J Control Release 2013; 172:292-304. [DOI: 10.1016/j.jconrel.2013.08.024] [Citation(s) in RCA: 123] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2013] [Accepted: 08/14/2013] [Indexed: 10/26/2022]
|
14
|
Environmental Fate of Chiral Pharmaceuticals: Determination, Degradation and Toxicity. ENVIRONMENTAL CHEMISTRY FOR A SUSTAINABLE WORLD 2012. [DOI: 10.1007/978-94-007-2439-6_1] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
15
|
Martinez M, Rathbone M, Burgess D, Huynh M. In vitro and in vivo considerations associated with parenteral sustained release products: A review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. J Control Release 2008; 129:79-87. [DOI: 10.1016/j.jconrel.2008.04.004] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2008] [Accepted: 04/04/2008] [Indexed: 12/17/2022]
|
16
|
Young AM, Ho SM. Drug release from injectable biodegradable polymeric adhesives for bone repair. J Control Release 2008; 127:162-72. [DOI: 10.1016/j.jconrel.2008.01.009] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2007] [Accepted: 01/22/2008] [Indexed: 01/19/2023]
|
17
|
Wang SH, Yin LN, Liang ZH, Lu SJ, Zeng S. Stereoselective behavior of a novel biodegradable racemic ketoprofen injectable implant in rats. Chirality 2007; 19:769-74. [PMID: 17687761 DOI: 10.1002/chir.20453] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The stereoselectivity of release of ketoprofen (KET) enantiomers from a biodegradable injectable implant containing racemic KET (rac-KET) was investigated in vivo. A pre-column chiral derivatization RP-HPLC method was employed to assay diastereoisomeric derivatives of R- and S-KET. The rac-KET injectable implant, once injected subcutaneously in rats, produced long-lasting plasma levels of S-KET, which were always greater than those of R-KET. The difference in enantiomer concentration was to be related to stereoselective release, due to stereoselective interaction between D,L-PLG in the implant and KET enantiomers, as well as the chiral inversion of KET in vivo. The rac-KET injectable implant provided the sustained release of S-KET with effective plasma levels maintained for about 8 wk after a single injection.
Collapse
Affiliation(s)
- Sheng-Hao Wang
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310031, People's Republic of China
| | | | | | | | | |
Collapse
|